Top Markets
Coin of the day
Sensorion SA Sensorion SA

Sensorion SA

ALSEN
Classificação em ações #13334
Sensorion SA, a clinical-stage biopharmaceutical company, develops drug... Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.
Preço da ação
$0.30840035
Valor de mercado
$94.37M
Variação (1 dia)
0.00%
Variação (1 ano)
-34.60%
País
FR
Negociar Sensorion SA (ALSEN)

Categoria

Receita da Sensorion SA (ALSEN)
Receita em Dec 2025 TTM: $2.73M
De acordo com os últimos relatórios financeiros da Sensorion SA, a receita atual da empresa (TTM) é $2.73M. Em 2023, a empresa obteve uma receita de $6.30M um aumento em relação a a receita do ano 2022, que foi de $5.29M. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Sensorion SA de 2011 a 2026
Receita no final de cada ano
Ano Receita Alterar
2026 (TTM) $2.73M -60.56%
2024 $6.92M 9.91%
2023 $6.30M 19.02%
2022 $5.29M 9.15%
2021 $4.85M 69.26%
2020 $2.86M 3.92%
2019 $2.76M 7.54%
2018 $2.56M 10.42%
2017 $2.32M 12,505.95%
2016 $18.41K -89.23%
2015 $171.03K -38.96%
2014 $280.18K -42.85%
2013 $490.29K 60.42%
2012 $305.63K 1,124,142.32%
2011 $27.19 0.00%
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
$52.05B 1,906,201.38%
DK
$12.26B 448,772.67%
US
$14.92B 546,366.42%
US
$9.08B 332,560.08%
BE
$6.29B 230,302.17%
NL